Cabozantinib (XL184, BMS-907351)

Cabozantinib (XL184, BMS-907351)

产品参数

货号 规格 操作
C126195-100mg 咨询
C126195-10mg 咨询
C126195-250mg 咨询
C126195-50mg 咨询
C126195-5mg 咨询
更多货号咨询>>
关闭

服务地域:全国

属性:产地:上海; 品牌:阿拉丁 ;货期:现货

上海阿拉丁生化科技股份有限公司

普通会员 普通会员
推荐产品推荐产品
产品描述产品描述
  • 分子式 C28H24FN3O5
  • 分子量501.52
  • Beilstein号
  • EC号
  • MDL号
  • PubChem编号

属性

溶解性 Soluble in DMSO (100 mg/ml at 25 °C), water (<1 mg/ml at 25 °C), ethanol (<1 mg/ml at 25 °C), and 30% propylene glycol, 5% Tween 80, 65% D5W (30 mg/ml at 25 °C).
存贮条件 储存温度-20°C

描述

应用 A potent VEGFR2 and Met inhibitor
产品介绍 Cabozantinib (XL184, BMS-907351)是一种有效的VEGFR2抑制剂,靶向作用于VEGFR2和c-Met时,IC50为0.035 nM ,也有效抑制c-Met、 Ret、 Kit、Flt-1/3/4、Tie2和AXL,IC50分别为1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM。
备注 Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively.Phas
生化机理 XL184 (Cabozantinib) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM. XL-184 also displays potent activity against Met, Ret, Kit, FLT1, FLT3, FLT4, Tie2, and AXL. XL184 at low concentration (0.1-0.5 μM) is sufficient to induce marked inhibition of constitutive and inducible Met phosphorylation and its resultant downstream signaling in MPNST cells, and inhibit HGF-induced MPNST cell migration and invasion.
别名 BMS-907351;博卡替尼;卡博替尼;卡赞替尼;N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-环丙烷二甲酰胺;XL184; BMS-907351; XL-184; XL184;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
店铺 店铺 咨询留言 咨询留言 热线电话 热线电话